Table: Hisamitsu - 9-MTH group results

Hisamitsu Pharmaceutical Co

13/01/2021 06:00

Jan 13 (Reuters)- 
             Hisamitsu Pharmaceutical Co Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Nov 30, 2020        Nov 30, 2019     Feb 28, 2021 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               80.82               99.08           127.00    
                   (-18.4 pct)         (-3.4 pct)       (-9.9 pct)  
  Operating            8.12               18.42            12.90    
                   (-55.9 pct)         (+15.4 pct)      (-43.2 pct) 
  Recurring            7.93               19.92            14.80    
                   (-60.2 pct)         (+14.4 pct)      (-42.3 pct) 
  Net                  5.72               15.42            10.60    
                   (-62.9 pct)         (+15.7 pct)      (-43.3 pct) 
  EPS               70.04 yen          187.36 yen       129.75 yen  
  EPS Diluted       69.97 yen          187.14 yen                   
  Ann Div                               83.00 yen        83.50 yen  
  -Q2 div           41.75 yen           41.50 yen                   
  -Q4 div                               41.50 yen        41.75 yen  
  
  NOTE - Hisamitsu Pharmaceutical Co Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T